Related Experiment Video
Updated: May 13, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Cardiac surgery for ergotamine-induced multivalvular heart disease
George Lazopoulos1, George Papaioannou, Michael Kantartzis
1Department of Cardiac Surgery, Athens Medical Center, Athens, Greece. lazopoulosg@ath.forthnet.gr
Abstract:
Ergotamine is used to abort or prevent vascular headache. Valvular heart disease as an adverse effect of long-term ergotamine therapy has been rarely reported in the English literature, with only a few cases published. It is hypothesized that ergot-derived agents stimulate serotonergic receptors (5-HT2B), causing proliferation of myofibroblasts, with subsequent thickening of valve leaflets and chords. This case presentation aims at increasing clinicians' awareness of this potential complication.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy VII: Pre and Post Operative Nursing Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

